Anti-aging Market Size Gain US$ 119.6 Bn By 2030

The anti-aging market size is projected to touch over US$ 119. billion by 2030, growing at a CAGR of 7.9% every year, according to a 2022 study by Precedence Research, the Canada-based market Insight Company.

For decades, the healthcare specialists and cosmetologists have been responsible with restoring youthful appearances and as a result discovering answers to age-related problems. Various goods and services are constantly being introduced to the anti-aging market with the goal of restoring youthful appearances. The botulinum toxin injection therapies, breast implants, plastic surgeries, and other anti-aging treatments and products have been introduced as a result of technological improvements and large investments in research and development efforts. The strict laws and regulations have prompted producers to introduce safer and more effective anti-aging treatments that deliver immediate effects to consumers, hence expanding the anti-aging market’s growth prospects.

The anti-aging market is propelled by not only by the aging population, but also by the young population who are starting in their mid-age, care about their skin, body, and hair in order to delay the aging process particularly with their appearance. The majority of the youthful population is through significant environmental changes and leading a busy lifestyle, which has resulted in an increase in many problems and necessitates making them more aware of their beauty, health, and appearance. As a result, one of the primary drivers of the anti-aging market is the aging population.

The base year for the study has been considered 2021, the historic year 2017 and 2020, the forecast period considered is from 2022 to 2030. The anti-aging market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

Download a FREE Sample Copy (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1597

Anti-aging Market Scope

Anti-aging Market: Report Highlights

• Based on the products, anti-wrinkle segment is estimated to be the most opportunistic segment during the forecast period. This can be attributed to increased awareness of the impact of anti-wrinkle products.
• Based on the demography, the generation X segment dominated the global anti-aging market in 2020 with highest market share. This is mostly due to people’s increasing awareness of their skin’s look and as a result the need to lessen the indications of aging.

Anti-aging Market Regional Snapshot

Asia-Pacific is the largest segment for anti-aging market in terms of region. The Asia-Pacific region has been identified as one of the most appealing destinations for cosmetic surgery with governments in region supporting medical tourism for cosmetic procedures, which is seen to be the region’s major drivers in the anti-aging market.

North America region is the fastest growing region in the anti-aging market. Due to well-established infrastructure, increasing average life expectancies, and presence of key market players in the region, the anti-aging market in North America is expected to grow significantly.

Anti-aging Market Dynamics

Drivers

Shift in consumer preferences

The widespread availability of at-home anti-aging equipment for wrinkle reduction, skin rejuvenation, cellulite reduction, and microdermabrasion has led to an increase in customer interest. Furthermore, these products are scientifically advanced and portable. The popularity of at-home anti-aging solutions is on the rise globally, with adults seeking ways to retain their young appearance and the elderly focusing on measures to keep the indications of ageing at check. As a result, this shift in consumer preference is driving the growth of the anti-aging market during the forecast period.

Restraints

High cost of anti-aging treatments

The doctors and healthcare providers treat people with various type of processes and treatments against anti-aging. The anti-aging treatments such as hair restoration, anti-pigmentation, adult acne therapy, breast augmentation, liposuction, and chemical peel are quite expensive in nature. These types of anti-aging treatments use different types of devices such as laser aesthetic devices, microdermabrasion devices, and radio frequency devices. The products used in the treatments are premium in nature. As a result, high cost of anti-aging treatments is hampering the growth of the global anti-aging market over the projection period.

Read Also: Floating Solar Market Size to Touch $ 10.09 Billion By 2030

Opportunities

Growing geriatric population

The geriatric population is growing at a rapid pace. This kind of people faces variety of skin problems. Those issues mostly include wrinkles. Therefore, doctors recommend them to use anti-aging creams and lotions. Therefore, there is huge demand for anti-aging products globally. Furthermore, due to technological advancements, the key market players are developing new techniques for the treatment of anti-aging among senior or old people. This factor is creating lucrative opportunities for the expansion of the global anti-aging market.

Challenges

Adverse side effects of anti-aging products

As customers want organic and natural skincare products, the popularity of chemical-based anti-aging and anti-wrinkle treatments is expected to decline. This is due to a number of incidents in which the negative consequences of these items have been revealed. These products may cause reactions ranging from moderate irritation to allergic contact dermatitis in people who are sensitive to them. The high-dose chemical content may raise the risk of skin allergies, limiting sales potential for anti-aging product manufacturers. Thus, adverse side effects of anti-aging products are a biggest challenge for the expansion of the anti-aging market.

Key Players

Some of the prominent players in the global anti-aging market include:

• Unilever Group
• GALDERMA LABORATORIES L.P.
• Procter & Gamble (P&G) Company
• Nu Skin Enterprises Inc.
• Hologic Inc.
• Pierre Fabre S.A.
• Shiseido Company Limited
• Candela Corporation
• Home Skinovations Ltd.
• Estee Lauder

Segments Covered in the Report

By Products

• Anti-wrinkle
• Hair color
• Ultraviolet absorption
• Anti-stretch mark

By Treatment

• Hair restoration
• Anti-pigmentation
• Adult acne therapy
• Breast augmentation
• Liposuction
• Chemical peel

By Demography

• Generation X
• Baby Boomers
• Generation Y
• Generation Z

By Devices

• Anti-cellulite treatment
• Laser aesthetic devices
• Microdermabrasion devices
• Radio frequency devices
• Others

By End User

• Hospitals
• Clinics
• Home healthcare

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Philippines
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC
  • North Africa
  • South Africa
  • Rest of the Middle East & Africa

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Anti-aging Market 

5.1. COVID-19 Landscape: Anti-aging Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Anti-aging Market, By Products Type

8.1. Anti-aging Market, by Products Type, 2022-2030

8.1.1. Anti-wrinkle

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Hair color

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Ultraviolet absorption

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Anti-stretch mark

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Anti-aging Market, By Treatment Type

9.1. Anti-aging Market, by Treatment Type, 2022-2030

9.1.1. Hair restoration

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Anti-pigmentation

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Adult acne therapy

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Breast augmentation

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Liposuction

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Chemical Peel

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Anti-aging Market, By Demography Type 

10.1. Anti-aging Market, by Demography Type, 2022-2030

10.1.1. Generation X

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Baby Boomers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Generation Y

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Generation Z

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Anti-aging Market, By Devices Type

11.1. Anti-aging Market, by Devices Type, 2022-2030

11.1.1. Anti-cellulite treatment

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Laser aesthetic devices

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Microdermabrasion devices

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Radio frequency devices

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Anti-aging Market, By End User Type

12.1. Anti-aging Market, by End User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Clinics

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Home healthcare

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Anti-aging  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.7. Market Revenue and Forecast, by End User (2017-2030)

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.4. Market Revenue and Forecast, by Devices (2017-2030)

13.2.5. Market Revenue and Forecast, by End User (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.7. Market Revenue and Forecast, by Devices (2017-2030)

13.2.8. Market Revenue and Forecast, by End User (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.10. Market Revenue and Forecast, by Devices (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Devices (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Devices (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Unilever Group

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. GALDERMA LABORATORIES L.P.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Procter & Gamble (P&G) Company

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Nu Skin Enterprises Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Hologic Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Pierre Fabre S.A.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Shiseido Company Limited

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Candela Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Home Skinovations Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Estee Lauder

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333

Frequently Asked Questions:

[sc_fs_multi_faq headline-0=”h6″ question-0=”Which are the driving factors of the anti-aging market?” answer-0=”The anti-aging market is propelled by not only by the aging population, but also by the young population who are starting in their mid-age, care about their skin, body, and hair in order to delay the aging process particularly with their appearance. ” image-0=”” headline-1=”h6″ question-1=”What is the current size of anti-aging market?” answer-1=”According to Precedence Research, the global anti-aging market was reached at US$ 60.42 billion in 2021 and is anticipated to rake US$ 119.6 billion by 2030. ” image-1=”” headline-2=”h6″ question-2=”What will be the CAGR of global anti-aging market?” answer-2=”The global anti-aging market is growing at a CAGR of 7.9% over the forecast period 2022 to 2030. ” image-2=”” headline-3=”h6″ question-3=”Who are the major players operating in the anti-aging market?” answer-3=”The major players operating in the anti-aging market are Unilever Group, GALDERMA LABORATORIES L.P., Procter & Gamble (P&G) Company, Nu Skin Enterprises Inc., Hologic Inc., Pierre Fabre S.A., Shiseido Company Limited, Candela Corporation, Home Skinovations Ltd., and Estee Lauder. ” image-3=”” headline-4=”h6″ question-4=”Which region will lead the global anti-aging market?” answer-4=”North America region will lead the global anti-aging market over the forecast period. ” image-4=”” count=”5″ html=”true” css_class=””]